Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inspire Medical Systems (INSP) EBIT Margin (2017 - 2025)

Inspire Medical Systems' EBIT Margin history spans 9 years, with the latest figure at 17.14% for Q4 2025.

  • For Q4 2025, EBIT Margin rose 384.0% year-over-year to 17.14%; the TTM value through Dec 2025 reached 5.59%, up 109.0%, while the annual FY2025 figure was 5.59%, 109.0% up from the prior year.
  • EBIT Margin for Q4 2025 was 17.14% at Inspire Medical Systems, up from 4.3% in the prior quarter.
  • Across five years, EBIT Margin topped out at 17.14% in Q4 2025 and bottomed at 38.88% in Q1 2021.
  • The 5-year median for EBIT Margin is 5.55% (2023), against an average of 6.63%.
  • The largest annual shift saw EBIT Margin skyrocketed 16357bps in 2021 before it plummeted -413bps in 2025.
  • A 5-year view of EBIT Margin shows it stood at 2.32% in 2021, then soared by 90bps to 0.24% in 2022, then skyrocketed by 2088bps to 4.83% in 2023, then surged by 175bps to 13.3% in 2024, then rose by 29bps to 17.14% in 2025.
  • Per Business Quant, the three most recent readings for INSP's EBIT Margin are 17.14% (Q4 2025), 4.3% (Q3 2025), and 1.53% (Q2 2025).